BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1026 related articles for article (PubMed ID: 26743180)

  • 21. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
    Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
    Jin W
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
    van der Horst G; Bos L; van der Pluijm G
    Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
    Marie-Egyptienne DT; Lohse I; Hill RP
    Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of inflammation-associated microenvironment in tumorigenesis and metastasis.
    Gao F; Liang B; Reddy ST; Farias-Eisner R; Su X
    Curr Cancer Drug Targets; 2014; 14(1):30-45. PubMed ID: 24200082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
    Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
    Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
    Jung HY; Fattet L; Yang J
    Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
    Yoshida GJ; Saya H
    Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
    Bocci F; Gearhart-Serna L; Boareto M; Ribeiro M; Ben-Jacob E; Devi GR; Levine H; Onuchic JN; Jolly MK
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):148-157. PubMed ID: 30587589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Stem Cells and Metastasis.
    Nandy SB; Lakshmanaswamy R
    Prog Mol Biol Transl Sci; 2017; 151():137-176. PubMed ID: 29096892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment.
    Gao T; Li JZ; Lu Y; Zhang CY; Li Q; Mao J; Li LH
    Biomed Pharmacother; 2016 May; 80():393-405. PubMed ID: 27133080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-mediated metastasis.
    Chang J; Erler J
    Adv Exp Med Biol; 2014; 772():55-81. PubMed ID: 24272354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Su L; Luo Y; Yang Z; Yang J; Yao C; Cheng F; Shan J; Chen J; Li F; Liu L; Liu C; Xu Y; Jiang L; Guo D; Prieto J; Ávila MA; Shen J; Qian C
    Cancer Res; 2016 Sep; 76(17):5054-67. PubMed ID: 27364559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.